REC-PFC merger gets president nod; micro-cap distress dominates
REC merger creates ₹10L cr giant; Axiscades sells unit; micro-cap insolvencies and massive orders mark the day
| Index | Level | Move |
|---|---|---|
| Bank Nifty | 58,291.50 | +0.61% |
| Nifty Auto | 27,353.95 | +1.36% |
| Nifty Energy | 39,481.45 | +0.77% |
| Nifty Financial Services | 29,422.60 | 0.00% |
| Nifty FMCG | 50,196.35 | +0.20% |
| Nifty Healthcare | 16,481.35 | 0.00% |
| Nifty IT | 27,276.45 | -0.59% |
| Nifty Media | 1,497.95 | -0.95% |
| Nifty Metal | 12,722.45 | +0.98% |
| Nifty Pharma | 25,866.25 | +0.47% |
| Nifty Private Bank | 16,648.10 | +2.00% |
| Nifty PSU Bank | 8,333.95 | -0.88% |
| Nifty Realty | 906.95 | +1.81% |
| Nifty Cement | 15,338.90 | 0.00% |
| Nifty Chemicals | 30,222.70 | 0.00% |
| Nifty Consumer Durables | 37,376.45 | 0.00% |
| Nifty Oil & Gas | 11,261.10 | 0.00% |
- Large-cap consolidation: REC-PFC merger and Affle promoter use set the tone for big balance-sheet moves.
- Mid-cap strategic shifts: Axiscades divests aerospace unit; Campus loses CFO without notice.
- Micro-cap disconnect: massive order wins (Fabtech, Vascon) contrast with insolvencies (EVOQ, Oswal) and huge liabilities (IVP).
- Concall credibility: Avanti Feeds reverses tariff refund stance; Arisinfra and Jinkushal flip-flop on guidance.
REC Ltd.
REC Ltd. merged into PFC after presidential approval, creating a combined entity with over ₹10 lakh crore in assets. For a large-cap already trading at a single-digit P/E, the consolidation forces a revaluation based on a single giant balance sheet. The share-exchange ratio will determine which set of shareholders got the better deal.
- ₹10 lakh crore+
- Combined assets of the proposed
- ₹96,021 cr
- Large cap mcap
- 5.89x
- P/E
- -21.69%
- PAT
- -5.02%
- Rev
- 6.33x
- D/E
Axiscades Technologies Ltd.
Axiscades sold its aerospace engineering unit to Akkodis for $206.3M, roughly a fifth of its market cap, shedding a division that contributed nearly a third of revenue. The deal refocuses the mid-cap on defence and high-end engineering, but the deferred revenue from Q4 and the earlier EBITDA miss mean the FY27 guidance of ₹1,377 cr now rests on a smaller, cleaner base.
- $206.3M
- Total deal value for aerospace
- ₹7,192 cr
- Mid cap mcap
- 100x
- P/E
- -98.15%
- PAT
- +1.88%
- Rev
- 0.29x
- D/E
Affle 3i Ltd.
Affle's promoters borrowed $170M against their entire 54.9% stake, a leveraged move for a company with near-zero corporate debt. The buyback component supports the stock, while the preferential issuance could dilute holders. It signals extreme conviction, but also extreme risk: any margin pressure on the loan puts control on the line.
- $170M
- Maximum loan facility secured
- ₹20,411 cr
- Large cap mcap
- 44.87x
- P/E
- +15.96%
- PAT
- +20.28%
- Rev
- 0.03x
- D/E
Fabtech Technologies Cleanrooms Ltd.
Fabtech Cleanrooms landed ₹153 cr in orders in May alone — 70% of last year's revenue and 31.5% of its market cap. The order book now exceeds 70% of market cap, locking in multi-year visibility without any non-binding LOIs. This shifts the micro-cap from project-driven to annuity-like, provided execution holds.
- ₹153.05 cr
- May 2026 order inflow
- ₹494 cr
- Micro cap mcap
- 31.24x
- P/E
- 14.08%
- ROE
- 0.01x
- D/E
SEPC Ltd.
SEPC won a ₹673 cr order from SAIL's IISCO expansion, the largest in its history and 62% of FY26 revenue. For a small-cap with a 'D' credit rating and severe liquidity distress, this is a rare credibility shot from a blue-chip PSU. But the company's record of audit qualifications and a cancelled MOIL order means the real test is execution, not press releases.
- ₹673.32 cr
- Combined value of two packages
- ₹1,281 cr
- Small cap mcap
- 23.92x
- P/E
- +37%
- PAT
- +132.45%
- Rev
- 0.24x
- D/E
IVP Ltd.
Mumbai Port ordered IVP to pay ₹136.81 cr in compensation — 80% of the micro-cap's market cap. What was a contingent liability footnote in the annual report is now an enforceable demand. For a company already fighting a fraud lawsuit from an ex-employee, this transforms legal risk into a direct claim on equity.
- ₹136.81 cr
- Compensation and damages ordered
- ₹165 cr
- Micro cap mcap
- 8.82x
- P/E
- +131.33%
- PAT
- +10.1%
- Rev
- 0.75x
- D/E
Duke Offshore Ltd.
Duke Offshore's promoters sold their 70.61% stake to Aspect Global for ₹20.87 cr, a full change of control at a 175% premium to the market cap. The new owner takes over a nano-cap with shrinking profits. The massive premium suggests the acquirer sees value in the oil exploration business that the market hasn't priced.
- ₹20.87 cr
- Price paid for the promoters'
- ₹23.13 cr
- Micro cap mcap
- -24.44%
- PAT
- 0.03x
- D/E
Vascon Engineers Ltd.
Vascon Engineers won a ₹347 cr government order, the largest in its history and 47% of its market cap. For a micro-cap whose revenue fell 35% and profit crashed 83% in FY26, this locks in multi-year work. The 36-month timeline provides visibility, but executing a project half the size of the company is a stretch.
- ₹347.43 cr
- Value of the single-largest order
- ₹805 cr
- Micro cap mcap
- 16.46x
- P/E
- -83.21%
- PAT
- -34.62%
- Rev
- 0.19x
- D/E
EVOQ Remedies Ltd.
Evoq Remedies entered insolvency over a ₹1.95 cr unpaid advance for oil. The company's market cap was ₹7 cr, revenue near zero, and the auditor had already flagged a going-concern doubt. This ends what was effectively a dead business. The two-month disclosure lag on the initial petition adds a governance scar.
- ₹1.95 cr
- Unpaid advance that triggered the
- ₹6.08 cr
- Micro cap mcap
- 0.2%
- ROE
- 0x
- D/E
Oswal Overseas Ltd.
Oswal Overseas was pushed into insolvency over a ₹2.25 cr debt, a small sum for a ₹158 cr market-cap company. The defence failed because no share purchase agreement existed and both sides acknowledged the debt. A manageable liability became existential due to poor documentation.
- ₹2.25 cr + interest
- Unpaid debt that triggered
- ₹156 cr
- Micro cap mcap
- -36%
- PAT
- -92.3%
- Rev
- -59.32x
- D/E
Samyak International Ltd.
Samyak International plans to raise ₹13.6 cr via a preferential issue — more than its entire ₹12 cr market cap. The steep discount means over 600% dilution for existing shareholders. New non-promoter investors hint at a possible change in control, making this a restructuring-level capital event.
- ₹13.6 cr
- Preferential issue size,
- ₹15.16 cr
- Micro cap mcap
- +13.82%
- PAT
- -57.59%
- Rev
- 0.05x
- D/E
RACL Geartech Ltd.
RACL Geartech's concall revealed it secured orders from Royal Enfield, Kawasaki, BMW and ZF, entering new segments like electric power steering and ATVs. The company guided for ₹565 cr in FY27 revenue and sustainable 20% growth. For a small-cap with debt/equity of 1.34, these premium wins justify the ₹77 cr capex, but execution on multiple new programs is the real test.
- 150,000 parts per year
- BRP Canada's high-volume order
- ₹1,587 cr
- Small cap mcap
- 32.43x
- P/E
- +90%
- PAT
- +50.83%
- Rev
- 1.34x
- D/E
Dhruv Consultancy Services Ltd.
Dhruv Consultancy won a ₹19.34 cr railway contract, equal to 36.5% of its market cap. This is a step-change for a micro-cap that saw revenue fall 70% in FY26. The 36-month project breaks Dhruv out of a highway consultancy niche and provides multi-year visibility.
- ₹19.34 cr
- Value of the new railway
- ₹54.51 cr
- Micro cap mcap
- -103.68%
- PAT
- -69.85%
- Rev
- 0.15x
- D/E
3B Films Ltd.
3B Films promoters sold 3.73% of the company in one day without explanation. For a nano-cap with a ₹62 cr market cap that just scrapped a ₹26 cr acquisition and posted a net loss, this is a sharp signal of promoter distress. Trust is the only cushion for such stocks, and this sale punctures it.
- 3.73%
- Promoter stake sold in a single
- ₹41.07 cr
- Micro cap mcap
- 22.28x
- P/E
- 14.3%
- ROE
- 2.9x
- D/E
-
In November 2025, Avanti Feeds management said it expected to pass on US tariff refunds to customers. In June 2026, it said it would keep an estimated $15-20 million as the importer of record, with no explanation for the reversal. The flip-flop undermines guidance credibility on an otherwise solid export story.
AVANTIFEED concall note -
Arisinfra said in May 2026 that its DAAS business required small working capital infusions. In June 2026, it claimed DAAS is completely asset-light with no working capital need. Also, the DAAS pipeline fell from ₹1,800+ cr to ₹1,500 cr in a month without explanation. The contradictory statements make the guidance harder to underwrite.
ARIS concall note -
Jinkushal Industries guided for ₹800 cr revenue and 7-9% PAT margins in October 2025. In June 2026, the revenue target dropped to ₹600-700 cr, PAT margin to 5-7%, and geographic expansion plans were shelved. Management claimed targets were unchanged, but the numbers tell a different story.
JKIPL concall note
-
Avanti Feeds reversed its stance on US tariff refunds, now expecting $15-20 million as importer of record after previously saying it would pass them to customers. The seafood exporter also noted feed margins squeezed by raw material inflation (fishmeal up 43%, soybean meal up 34%). FY27 feed volume guided at 580,000 MT (+3.2%), but the refund reversal adds a credibility question.
AVANTIFEED concall note -
RACL Geartech's concall flags new wins from Royal Enfield, Kawasaki, BMW and ZF, entering electric power steering and ATV drivelines. Management guided for FY27 revenue of ₹565 cr ±5% and sustainable 20% growth, backed by ₹77 cr capex. EBITDA margin improved to 25.2% in FY26, and debt-equity fell from 1.3x to 0.6x. The premium pivot is promising, but execution on multiple new programmes will be key.
RACLGEAR concall note -
Afcom Holdings' fleet expansion is fully funded via a ₹200 cr preferential issue and ₹200 cr QIP, with four Boeing 777s in play. Management targets at least doubling FY26 revenue of ₹587.72 cr in FY27, backed by geopolitical tailwinds. Each 777 is expected to generate ~₹75 cr monthly revenue. The risk is normalization of global conflicts, but for now, the war bet is financed.
AFCOM concall note -
Health X reversed its stance on capital needs, now taking ₹154 cr in bank loans after saying no external capital was needed for five years. Management also admitted that the JITHO transition hurt branded sales, reversing earlier denial of channel conflict. FY30 revenue target of ₹6,000 cr remains, but the credibility gap on capital and conflict needs bridging.
HEALTHX concall note
- IN CPI Inflation (prev 3.48% YoY) — no major divergence expected; market impact muted